Home › Funds › Two Sigma Investments › AMLX
Two Sigma Investments position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)593.43K sh
Reported value held$10.66M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 43.80K | $644.74K | New |
| Q1 2024 | 1.43M | $4.07M | Add |
| Q2 2024 | 1.30M | $2.47M | Reduce |
| Q3 2024 | 367.24K | $1.19M | Reduce |
| Q4 2024 | 651.52K | $2.46M | Add |
| Q1 2025 | 762.05K | $2.70M | Add |
| Q2 2025 | 558.85K | $3.58M | Reduce |
| Q3 2025 | 98.42K | $1.34M | Reduce |
| Q4 2025 | 344.40K | $4.16M | Add |
| Q1 2026 | 161.94K | $2.25M | Reduce |
| Q2 2026 | 593.43K | $10.66M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMLX
- Fidelity Management & Research (FMR) 16.73M sh · $300.43M · Q2 2026
- BlackRock Inc 8.83M sh · $158.53M · Q2 2026
- Vanguard Group 5.80M sh · $70.12M · Q4 2025
- Janus Henderson Group 4.99M sh · $69.26M · Q1 2026
- Morgan Stanley 3.13M sh · $56.23M · Q2 2026
- Franklin Resources 2.95M sh · $52.99M · Q2 2026
- Goldman Sachs Group 2.86M sh · $51.33M · Q2 2026
- Geode Capital Management 2.34M sh · $41.95M · Q2 2026
- JPMorgan Chase & Co 1.86M sh · $34.92M · Q2 2026
- Northern Trust Corp 831.74K sh · $14.94M · Q2 2026
- Bank of America Corp 821.84K sh · $14.76M · Q2 2026
- Charles Schwab Investment Management 725.03K sh · $13.02M · Q2 2026